VCBeat (WeChat ID: vcbeat) has learned that Weiyi Orthopedics has announced the completion of a $100 million Series B financing round. The round was led by Sheares Healthcare Fund, a specialized healthcare investment fund under Temasek, Singapore’s sovereign wealth fund, with follow-on investments from Tencent, ZhenFund, and the company’s founders. China Renaissance served as the exclusive financial advisor for this transaction.
Relying on its big data-centric strategy that penetrates the entire orthopedics industry, Weiyi Orthopedics has bucked the trend to once again garner favor from capital markets. This not only represents a high recognition of Weiyi Orthopedics’ commercial value and development potential but also highlights the long-term vision of investment institutions in leveraging technological innovation to enhance future healthcare and wellness services, thereby instilling significant confidence across the entire internet healthcare sector.
According to reports, since its establishment in 2013, Weiyi Orthopedics, as the first internet healthcare platform in China dedicated exclusively to the field of orthopedics, has steadily advanced with the mission of “empowering doctors’ futures and safeguarding patients’ health.” Currently, Weiyi Orthopedics has registered over 150,000 orthopedic surgeons, covers more than 17,000 hospitals, and has established two Weiyi Orthopedics Diagnosis and Treatment Centers in Yinchuan and Chongqing. Through years of accumulation, Weiyi has evolved from an educational platform for orthopedic surgeons into a “one-stop” orthopedic service platform integrating education and training, precision marketing, surgical diagnosis and treatment, centralized procurement of medical consumables, and clinical research. It has fostered a new ecosystem in the orthopedic industry, centered on patient services, focused on empowering physicians, supported by interconnected online platforms and offline hospital networks, and driven by big data and artificial intelligence technologies. This ecosystem optimizes patients’ medical experience, enhances healthcare efficiency, expands medical supply capacity, and simultaneously supports national efforts to control health insurance expenditures.
In recent years, amid the trend of consumption upgrading, the internet healthcare industry has unleashed unprecedented vitality. While many internet healthcare companies were still exploring their paths, Weiyi had already taken an early lead in the orthopedics sector. With its “Weiyi Model,” featuring intelligent end-to-end management covering “information collection – imaging analysis – physician matching – online consultation – surgical treatment – medical consumables delivery – rehabilitation follow-up,” Weiyi has emerged as a practitioner of new healthcare models.
Ms. Liu Zhengrong, Founder and CEO of Weiyi Orthopedics, stated: “The original intention behind establishing Weiyi was to enable more physicians to access specialized education and training, thereby allowing them to provide better diagnostic and therapeutic services to a broader patient population. Healthcare is a critical issue concerning public welfare and social livelihood, requiring a grounded, diligent, and conscientious approach. Only by genuinely prioritizing the interests of patients and physicians can we earn their trust and achieve success in the internet healthcare industry.”
It is reported that following this round of financing, in addition to integrating multi-party resources to jointly expand its offline medical network layout, optimizing orthopedic diagnosis and treatment services, and enhancing patient care experiences, Weiyi Orthopedics will further promote the decentralization of systematic orthopedic education. By aggregating high-quality physician resources and empowering doctors, the company aims to achieve standardized and high-quality medical education. Leveraging professional big data in orthopedics, Weiyi Orthopedics supports research and development in the field of orthopedic artificial intelligence, driving dual breakthroughs in efficiency and effectiveness for the industry, and establishing a nationwide medical ecosystem.